BR1102 : Triple negative breast cancer (the most of TNBC) tissue array ,including pathology grade,TNM, clinical stage (AJCC 8th edition) and IHC (ER/PR/Her-2) results, 110 cases/110 cores (core size 1.0mm)
  • $465.00
  • Unstained
  • H&E
-+
Microarray Panel Triple negative breast carcinoma,with positive control and normal adjacent breast (NAT) breast tissue microarray, containing 104 cases TNBC, 3 positive control, 3 NAT tissue, single core per case
Cores 110
TissueArray.Com Tissue Array BR1102
Cases 110
Row number 10
Column number 11
Core Diameter (mm) 1
Thickness (µm) 5
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: TissueArray.Com Tissue Array
1234567891011 
ABreBreBreBreBreBreBreBreBreBreBre 
BBreBreBreBreBreBreBreBreBreBreBre 
CBreBreBreBreBreBreBreBreBreBreBre 
DBreBreBreBreBreBreBreBreBreBreBre 
EBreBreBreBreBreBreBreBreBreBreBre 
FBreBreBreBreBreBreBreBreBreBreBre 
GBreBreBreBreBreBreBreBreBreBreBre 
HBreBreBreBreBreBreBreBreBreBreBre 
IBreBreBreBreBreBreBreBreBreBreBre 
JBreBreBreBreBreBreBreBreBreBreBreMarked point
Legend: Bre - Breast

- Malignant tumor, - Malignant tumor (stage IA), - Malignant tumor (stage IIA), - Malignant tumor (stage IIB), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIB), - Malignant tumor (stage IIIC), - NAT

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos.
No.
Age
Sex
Organ/Anatomic Site
Pathology diagnosis
TNM
Grade
Stage
Type
ER
PR
HER2
Ki67
Image
A1
1
54
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
2+
-
A2
2
46
F
Breast
Invasive carcinoma of no special type
T2N3aM0
2
IIIC
Malignant
-
-
1+
+,20%
A3
3
45
F
Breast
Invasive carcinoma of no special type
T2N3aM0
2
IIIC
Malignant
-
-
2+
+,2%
A4
4
50
F
Breast
Invasive carcinoma of no special type
T4aN0M0
2
IIIB
Malignant
-
-
2+
+,10%
A5
5
55
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
+,50%
A6
6
61
F
Breast
Invasive carcinoma of no special type
T2N1aM0
2
IIB
Malignant
-
-
0
+,5%
A7
7
50
F
Breast
Invasive carcinoma of no special type
T2N1M0
2
IIB
Malignant
-
-
0
-
A8
8
34
F
Breast
Invasive carcinoma of no special type
T1cN1M0
2
IIA
Malignant
-
-
0
+,60%
A9
9
49
F
Breast
Invasive carcinoma of no special type
T1CN0M0
2
IA
Malignant
-
-
1+
+,60%
A10
10
51
F
Breast
Invasive carcinoma of no special type
T2N1M0
2
IIB
Malignant
-
-
1+
+,60%
A11
11
81
F
Breast
Invasive carcinoma of no special type
T1cN0M0
2
IA
Malignant
-
-
1+
+,20%
B1
12
58
F
Breast
Invasive carcinoma of no special type
T1cN3M0
2
IIIC
Malignant
-
-
1+
-
B2
13
47
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
-
B3
14
35
F
Breast
Invasive carcinoma of no special type
T2N0M0
1
IIA
Malignant
-
-
0
-
B4
15
60
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
+,15%
B5
16
51
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
2+
+,10%
B6
17
53
F
Breast
Invasive carcinoma of no special type
T2N2M0
2
IIIA
Malignant
-
-
2+
+,30%
B7
18
43
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
0
+,15%
B8
19
54
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
+,35%
B9
20
52
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
2+
+,55%
B10
21
27
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
2+
+,10%
B11
22
52
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
+,50%
C1
23
49
F
Breast
Invasive carcinoma of no special type
T2N2M0
2
IIIA
Malignant
-
-
0
+,5%
C2
24
48
F
Breast
Invasive carcinoma of no special type
T2N2M0
2
IIIA
Malignant
-
-
2+
+,2%
C3
25
44
F
Breast
Invasive carcinoma of no special type
T2N1M0
2
IIB
Malignant
-
-
0
+,5%
C4
26
31
F
Breast
Invasive carcinoma of no special type
T1cN1M0
2
IIA
Malignant
-
-
1+
+,20%
C5
27
40
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
1+
+,90%
C6
28
30
F
Breast
Invasive carcinoma of no special type
T4aN2aM0
2
IIIB
Malignant
-
-
0
+,60%
C7
29
40
F
Breast
Invasive carcinoma of no special type
T2N1M0
2
IIB
Malignant
-
-
0
+,30%
C8
30
47
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
0
-
C9
31
55
F
Breast
Invasive carcinoma of no special type
T1bN1M0
2
IIA
Malignant
-
-
1+
+,50%
C10
32
54
F
Breast
Invasive carcinoma of no special type
T2N2M0
2
IIIA
Malignant
-
-
1+
+,30%
C11
33
61
F
Breast
Invasive carcinoma of no special type
T4aN1aM0
2
IIIB
Malignant
-
-
1+
+,20%
D1
34
53
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
0
+,20%
D2
35
43
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,15%
D3
36
32
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,5%
D4
37
54
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,60%
D5
38
53
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
1+
-
D6
39
51
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,80%
D7
40
56
F
Breast
Invasive carcinoma of no special type
T2N1M0
2
IIB
Malignant
-
-
1+
+,35%
D8
41
53
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IA
Malignant
-
-
2+
+,40%
D9
42
41
F
Breast
Invasive carcinoma of no special type
T3N2M0
3
IIIA
Malignant
-
-
2+
+,60%
D10
43
40
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
2+
+,20%
D11
44
45
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
2+
+,25%
E1
45
47
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,20%
E2
46
43
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,20%
E3
47
60
F
Breast
Invasive carcinoma of no special type
T2N2M0
3
IIIA
Malignant
-
-
1+
+,40%
E4
48
55
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,30%
E5
49
70
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,50%
E6
50
32
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,15%
E7
51
40
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
1+
+,60%
E8
52
71
F
Breast
Invasive carcinoma of no special type
T2N2M0
3
IIIA
Malignant
-
-
1+
+,20%
E9
53
31
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
2+
+,30%
E10
54
33
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
0
+,50%
E11
55
50
F
Breast
Invasive carcinoma of no special type
T1cN0M0
3
IA
Malignant
-
-
1+
+,65%
F1
56
68
F
Breast
Invasive carcinoma of no special type
T1cN0M0
3
IA
Malignant
-
-
1+
+,50%
F2
57
61
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,10%
F3
58
61
F
Breast
Invasive carcinoma of no special type
T1cN0M0
3
IA
Malignant
-
-
0
+,60%
F4
59
41
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,5%
F5
60
46
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
2+
+,70%
F6
61
62
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,80%
F7
62
55
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
2+
+,30%
F8
63
36
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
-
F9
64
61
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
-
F10
65
63
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
-
F11
66
52
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
0
+,40%
G1
67
48
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,5%
G2
68
46
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
-
G3
69
52
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
-
G4
70
40
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,50%
G5
71
33
F
Breast
Invasive carcinoma of no special type
T3N3M0
3
IIIC
Malignant
-
-
0
+,30%
G6
72
58
F
Breast
Invasive carcinoma of no special type
T4N1M0
3
IIIB
Malignant
-
-
1+
+,40%
G7
73
51
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,15%
G8
74
43
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,40%
G9
75
47
F
Breast
Invasive carcinoma of no special type
T4N0M0
3
IIIB
Malignant
-
-
2+
-
G10
76
86
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
2+
+,45%
G11
77
50
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,60%
H1
78
38
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,80%
H2
79
44
F
Breast
Invasive carcinoma of no special type
T2N2M0
3
IIIA
Malignant
-
-
0
+,60%
H3
80
44
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,10%
H4
81
27
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,80%
H5
82
72
F
Breast
Invasive carcinoma of no special type
T4N0M0
3
IIIB
Malignant
-
-
1+
+,50%
H6
83
52
F
Breast
Invasive carcinoma of no special type
T3N3M0
3
IIIC
Malignant
-
-
1+
+,60%
H7
84
49
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
0
+,30%
H8
85
44
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
2+
+,40%
H9
86
48
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
2+
+,60%
H10
87
40
F
Breast
Invasive carcinoma of no special type
T3N0M0
2
IIB
Malignant
-
-
0
+,20%
H11
88
66
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,55%
I1
89
70
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
-
I2
90
48
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,30%
I3
91
55
F
Breast
Invasive carcinoma of no special type
T2N1M0
3
IIB
Malignant
-
-
1+
+,45%
I4
92
55
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,40%
I5
93
34
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,30%
I6
94
58
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,15%
I7
95
46
F
Breast
Invasive carcinoma of no special type
T3N0M0
2
IIB
Malignant
-
-
2+
-
I8
96
62
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
1+
+,20%
I9
97
57
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,35%
I10
98
50
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
1+
+,60%
I11
99
41
F
Breast
Invasive carcinoma of no special type
T3N0M0
2
IIB
Malignant
-
-
0
+,50%
J1
100
42
F
Breast
Invasive carcinoma of no special type
T2N0M0
3
IIA
Malignant
-
-
0
+,70%
J2
101
60
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
0
+,30%
J3
102
71
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
2+
+,15%
J4
103
50
F
Breast
Invasive carcinoma of no special type
T2N0M0
2
IIA
Malignant
-
-
0
-
J5
104
65
F
Breast
Invasive carcinoma of no special type
T3N0M0
3
IIB
Malignant
-
-
0
+,5%
J6
105
53
F
Breast
Invasive carcinoma of no special type
T3N0M0
2
IIB
Malignant
+++,100%
-
3+
+,15%
J7
106
45
F
Breast
Invasive carcinoma of no special type
T3N1M0
2
IIIA
Malignant
+++,100%
+++,80%
3+
+,20%
J8
107
40
F
Breast
Invasive carcinoma of no special type
T2N2M0
2
IIIA
Malignant
-
-
3+
+,50%
J9
108
48
F
Breast
NAT breast tissue
-
-
-
NAT
+
++
0
-
J10
109
49
F
Breast
NAT breast tissue (fibrous tissue)
-
-
-
NAT
*
*
*
*
J11
110
47
F
Breast
NAT breast tissue
-
-
-
NAT
+
+
0
-
-
0
42
M
Adrenal gland
Pheochromocytoma (tissue marker)
-
Malignant
Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review
 
  • Product Code: BR1102
  • Availability: In Stock

Tags: Stage (TNM), With normal control (), Single core per case